GHK-Cu serums vs GHK-Cu injections: pros, cons and what the science says

What is GHK-Cu, and why is it blue?

GHK is a tripeptide, a chain of three amino acids (glycine, histidine and lysine). It was first isolated from human plasma by Loren Pickart in 1973.¹ It binds copper tightly, and the copper complex, GHK-Cu, is the form used in skincare. On ingredient lists you'll see it as copper tripeptide-1.

Your body makes it naturally, and levels decline with age. According to reviews by Pickart and Margolina, plasma GHK is about 200 ng/mL at age 20 and about 80 ng/mL by age 60.² This decline is a big part of the ingredient's appeal. It's also worth knowing that Pickart, who wrote much of the literature, has commercial links to copper-peptide products.

The blue colour is simple chemistry. The peptide holds copper in its Cu(II) state through nitrogen atoms in its backbone and histidine side chain.³ Like many Cu(II) complexes, it absorbs orange-red light and so looks blue. In short, a blue copper serum is blue because of the copper.

Topical GHK-Cu serums: what the evidence shows

In the lab

The strongest data comes from cell studies. In a 1988 study on human skin fibroblasts (the cells that make collagen), GHK-Cu increased collagen production. The effect began at extremely low concentrations and peaked at around one nanomolar.⁴ Later lab work linked it to the production of glycosaminoglycans (moisture-binding molecules in skin) and to the balance of enzymes that remodel skin's support structure.⁵ This is promising, but results in a dish don't automatically carry over to a face.

On real skin

The human studies are few and small:

• Abdulghani et al. (1998): a small pilot on thigh skin. Biopsies showed more collagen in 70% of women using a GHK-Cu cream, against 50% with vitamin C and 40% with retinoic acid. It was published in a minor journal that isn't indexed on PubMed.⁵
• Leyden et al. (2002): a 12-week study of 71 women using a copper-peptide face cream, presented at a dermatology meeting. It reported improvements in laxity, clarity and the look of fine lines. A related eye-cream study in 41 women was also reported. Neither was peer-reviewed as a full paper.⁵
• Badenhorst et al. (2016): a randomised, double-blind trial in 40 women aged 40–65. After 8 weeks of twice-daily use, a GHK-Cu serum in a lipid carrier reduced measured wrinkle volume by 55.8% compared with the control serum. The journal's publisher has a mixed reputation, so read this as encouraging but not conclusive.⁶

Taken together, these studies suggest GHK-Cu can help improve the look of fine lines, firmness and texture. But they are small, short, and often funded by the industry. There is no large independent trial.

Does it get into the skin?

Partly. GHK-Cu is small for a peptide, but it is water-loving and charged, which the skin barrier resists. In a lab study on human skin, measurable amounts of the copper peptide entered the skin and some passed through over 48 hours.⁷ That is encouraging, though how much reaches living cells in everyday use depends on the formula.

Concentration and tolerability

Cosmetic levels are lower than marketing often implies. The US Cosmetic Ingredient Review panel judged copper tripeptide-1 safe as used. It noted typical use concentrations of under 10 parts per million, and industry reports of 1–30 ppm.⁸ Because the cell data shows activity at nanomolar levels, more is not necessarily better. Irritation appears uncommon, but a patch test is still sensible.

Pairing it with other actives

• Vitamin C (ascorbic acid): ascorbate can chemically reduce Cu(II) to Cu(I), which may destabilise the complex. We found no study on the combination itself, so standard formulation advice is to use them at different times of day (vitamin C in the morning, copper peptide in the evening).
• Exfoliating acids (AHAs/BHAs): peptide-copper complexes are generally formulated near neutral pH. Lab work on GHK-Cu delivery used a pH 6 buffer for stability.⁹ Low-pH acids are best used on alternate nights.
• Retinoids and bakuchiol: there's no evidence of a harmful interaction. Bakuchiol is a gentle, plant-derived option that layers easily with peptides, while strong retinoids may call for a slower start to limit dryness.
• Hydrators and niacinamide (such as hyaluronic acid) are easy companions.

GHK-Cu injections: the hype and the gaps

How people use them

Injectable GHK-Cu is usually sold as a freeze-dried powder. Users mix it with sterile water and inject it under the skin (subcutaneously). It is sold either online as a "research peptide" or through wellness and aesthetics clinics. Claims range from better skin and hair to faster healing and "anti-ageing" in general. Journalists in 2026 have documented the trend spreading through social media.¹⁵

The human evidence

We found no controlled human trial of injected GHK-Cu for skin or ageing. The wound-healing and collagen findings come from animals and cell studies. As researchers writing in The Conversation put it, the mouse findings "have not been confirmed in humans".¹⁴ The widely shared gene data, showing that GHK changes the activity of thousands of genes, comes from cancer cell lines in a database, not from people.¹⁶

Safety unknowns

• Product quality: independent testing reported by TIME found that at least 20% of unapproved peptides tested were mislabelled.¹⁵ Contamination, wrong doses and missing sterility or endotoxin testing are recurring concerns.¹⁴
• Immune reactions: the US FDA flagged a risk of immunogenicity (unwanted immune responses) from peptide aggregation and impurities in compounded injectable GHK-Cu.¹⁰
• Injection-site problems: redness, lumps and, at worst, infections or abscesses.¹⁴
• Dosing and copper load: there is no established human dose. The effect of repeated doses of injected copper on the body has not been studied.

Regulation

US: GHK-Cu is not FDA-approved for any use. In 2023 the FDA placed injectable GHK-Cu on its list of compounding substances that may present significant safety risks. In April 2026 it was moved off that list because the nominations were withdrawn, not because it was found to be safe.¹⁰ A formal advisory review is expected by early 2027.¹¹

UK: we found no UK licence for any injectable GHK-Cu product. The MHRA has said it disregards "research purposes" labels used to sidestep medicines rules,¹² and the British College of Aesthetic Medicine warned in 2026 that "natural" peptides are not automatically safe.¹³

Cost

Prices vary widely between grey-market vials and clinic programmes, and we found no reliable source for typical costs. Clinic prices usually add the cost of consultations and repeat visits.

Side by side

Swipe the table sideways to see both columns.

Where the science stands

• Reasonably established: GHK-Cu boosts collagen-related activity in cells; it penetrates human skin in the lab; it is considered safe as a cosmetic ingredient at typical levels.
• Promising: small facial studies on the look of wrinkles and firmness; animal wound-healing research; gene-expression data.
• Unknown: whether injecting it does anything useful in people; the right dose; long-term effects of repeated injections; how reliably grey-market products are what they claim to be.